MC
HAE icon

Maverick Capital’s Haemonetics HAE Stock Holding History

Maverick Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,074
Closed -$518K – 360
2024
Q1 		$518K Buy
+6,074
New +$477K 0.01% 208
2020
Q2 		– Sell
-3,463
Closed -$345K – 615
2020
Q1 		$345K Sell
3,463
-5,744
-62% -$623K 0.01% 398
2019
Q4 		$1.06M Buy
+9,207
New +$1.11M 0.02% 307
2019
Q3 		– Sell
-89,560
Closed -$10.8M – 361
2019
Q2 		$10.8M Buy
+89,560
New +$8.81M 0.16% 63
2018
Q4 		– Sell
-20,830
Closed -$2.39M – 275
2018
Q3 		$2.39M Buy
+20,830
New +$2.16M 0.03% 210

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital's HAE Position: Q2 2024 in Review

Maverick Capital sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 6,074 shares — an estimated $518K sold.

Maverick Capital first reported a position in HAE in Q3 2018 and held it in 5 quarters. The position peaked at $10.8M in Q2 2019. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Maverick Capital reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Maverick Capital sold 6,074 Haemonetics shares in Q2 2024, an estimated $518K.
  • Maverick Capital first reported a position in Haemonetics in Q3 2018 and held it in 5 quarters.
  • Maverick Capital's Haemonetics position peaked at $10.8M in Q2 2019.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.